InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Explore the full record of transactions filed by Rankin Aubrey. Insider active across 1 companies, notably Revance Therapeutics, Inc.. In total, 9 filings have been logged. Total volume traded: €5.3m. The latest transaction was disclosed on 15 March 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
€19,7971,372 shares@ €14.42910.4% of flow
Common Stock
SEC:0001209191-22-019718:0·
€382,86630,000 shares@ €12.762213.9% of flow
Common Stock
SEC:0001479290-21-000171·
Ideal exit: 30 Aug 2022 (T+270)
€382,86630,000 shares@ €12.76226.9% of flow
Common Stock
SEC:0001479290-21-000171:0·
Ideal exit: 30 Aug 2022 (T+270)
€109,1794,949 shares@ €22.06084.0% of flow
Common Stock
SEC:0001479290-21-000152·
€109,1794,949 shares@ €22.06082.0% of flow
Common Stock
SEC:0001479290-21-000152:0·
€869,46134,332 shares@ €25.325131.6% of flow
Common Stock
SEC:0001479290-21-000141·
€869,46134,332 shares@ €25.325115.7% of flow
Common Stock
SEC:0001479290-21-000141:0·
€1m55,382 shares@ €25.169950.6% of flow
Common Stock
SEC:0001479290-21-000139·
€1m55,382 shares@ €25.169925.2% of flow
Common Stock
SEC:0001479290-21-000139:0·
9 of 9 declarations
About Rankin Aubrey
Rankin Aubrey is a director at Revance Therapeutics, Inc.
